|
Sequences
The following sequences are available for this feature:
mRNA from alignment at ch2:459942..461076- Legend: polypeptideCDSexon Hold the cursor over a type above to highlight its positions in the sequence below. >KYF_001446-T1 ID=KYF_001446-T1|Name=KYF_001446-T1|organism=Aspergillus niger KYF3|type=mRNA|length=1135bp|location=Sequence derived from alignment at ch2:459942..461076- (Aspergillus niger KYF3) ATGACCAAACCCATAATCCTCCACCTCGGCGACCCCATCGCCTACAACCA
CGACCTCTACAACGACCCCCTCTCCACCCGCTTCACCATCATCCGCGACA
CCTCCCCAACCCGCGAAGCCTTCATCGAGGCGCTGAAAACCAACAAGTAA
GACCTCTTCCTCTTTTATTCATCTCCACACCCACACTAAGAAATAACCCA
GATACGGCCCCTTCGTCGCCATCTTCCGCCCACACTTCTCCTCCGGCACG
ACCATGTCCCCCTGGGACGCCGACCTGGTCTCCCTCCTTCCTCCCAGCGT
CAAAATCTTCGCCTCAGCGGGAGCAGGCTACAACGACATCTCCGTCCCCT
CGCTCACCGCGCGCGGAATATACTACACCAACGGGGCGGGCGCCTCCGAC
GAAGCCGTCGCCGACACAACACTATACATGATCCTGAGCGTGTTTAGAAA
CTTCACTGCATCGCAGATCGCGGCGCGGTCGGGCGATACGGAGAGGTTTC
TAGAATGTCATCGGAATCTGGCGGGCGTGTCGACGAATCCGAGGGGGAAG
GTTCTGGGATTGATTGGACTGGGGAGGATTGGGAGTGAGGTGGTGAGGAA
GGTGAGGGGTGGGTTAGGGATGGAGGTTGTTTATTATGATGCGGTACGGT
TGAGTGAGGAGAGGGAGAGGGAGTTGGGGGTGAGATGGGGCGGGGGGATT
AGGGGGGTGTTGGAGGGGGCGGATTGTGTGTCGGTGCATTGTCCGTTGAC
TGAGGGGACCAGGGGGTTGATCGATAAGGAGAAGATTGGGTGGATGAGGG
ATGGGGTGAGGGTTGTTAATGTGGCCAGGGGGGGTGTGGTGGTTGAGGAG
GATTTGGTGCAGGGGTTGAGGAGTGGGAAGGTGGCTGCTGCGGCGTTGGA
TGTTCATGAGTTTGAGCCCGTTGTGGATGGTAGACTGAGGGAGATGGAGA
ATGTTACGCTTACGACGCATGTTGGGGGTGGGGCGGTTGAGACGAGGATT
GGGTTTGAGAGGTTGGCGATGGAGAATATTTTGAGGGTAGTCGGGGATGA
TGGGGAGGTTGTCGGGGAGCCGGTCACGGCTGTTAATGGGAGGGAGGTGA
GGGAGGTGTGGGAGAGGATGGGCAAGGGGGAGTGA back to topCoding sequence (CDS) from alignment at ch2:459942..461076- >KYF_001446-T1 ID=KYF_001446-T1|Name=KYF_001446-T1|organism=Aspergillus niger KYF3|type=CDS|length=2160bp|location=Sequence derived from alignment at ch2:459942..461076- (Aspergillus niger KYF3) ATACGGCCCCTTCGTCGCCATCTTCCGCCCACACTTCTCCTCCGGCACGA CCATGTCCCCCTGGGACGCCGACCTGGTCTCCCTCCTTCCTCCCAGCGTC AAAATCTTCGCCTCAGCGGGAGCAGGCTACAACGACATCTCCGTCCCCTC GCTCACCGCGCGCGGAATATACTACACCAACGGGGCGGGCGCCTCCGACG AAGCCGTCGCCGACACAACACTATACATGATCCTGAGCGTGTTTAGAAAC TTCACTGCATCGCAGATCGCGGCGCGGTCGGGCGATACGGAGAGGTTTCT AGAATGTCATCGGAATCTGGCGGGCGTGTCGACGAATCCGAGGGGGAAGG TTCTGGGATTGATTGGACTGGGGAGGATTGGGAGTGAGGTGGTGAGGAAG GTGAGGGGTGGGTTAGGGATGGAGGTTGTTTATTATGATGCGGTACGGTT GAGTGAGGAGAGGGAGAGGGAGTTGGGGGTGAGATGGGGCGGGGGGATTA GGGGGGTGTTGGAGGGGGCGGATTGTGTGTCGGTGCATTGTCCGTTGACT GAGGGGACCAGGGGGTTGATCGATAAGGAGAAGATTGGGTGGATGAGGGA TGGGGTGAGGGTTGTTAATGTGGCCAGGGGGGGTGTGGTGGTTGAGGAGG ATTTGGTGCAGGGGTTGAGGAGTGGGAAGGTGGCTGCTGCGGCGTTGGAT GTTCATGAGTTTGAGCCCGTTGTGGATGGTAGACTGAGGGAGATGGAGAA TGTTACGCTTACGACGCATGTTGGGGGTGGGGCGGTTGAGACGAGGATTG GGTTTGAGAGGTTGGCGATGGAGAATATTTTGAGGGTAGTCGGGGATGAT GGGGAGGTTGTCGGGGAGCCGGTCACGGCTGTTAATGGGAGGGAGGTGAG GGAGGTGTGGGAGAGGATGGGCAAGGGGGAGTGAATGACCAAACCCATAA TCCTCCACCTCGGCGACCCCATCGCCTACAACCACGACCTCTACAACGAC CCCCTCTCCACCCGCTTCACCATCATCCGCGACACCTCCCCAACCCGCGA AGCCTTCATCGAGGCGCTGAAAACCAACAAATACGGCCCCTTCGTCGCCA TCTTCCGCCCACACTTCTCCTCCGGCACGACCATGTCCCCCTGGGACGCC GACCTGGTCTCCCTCCTTCCTCCCAGCGTCAAAATCTTCGCCTCAGCGGG AGCAGGCTACAACGACATCTCCGTCCCCTCGCTCACCGCGCGCGGAATAT ACTACACCAACGGGGCGGGCGCCTCCGACGAAGCCGTCGCCGACACAACA CTATACATGATCCTGAGCGTGTTTAGAAACTTCACTGCATCGCAGATCGC GGCGCGGTCGGGCGATACGGAGAGGTTTCTAGAATGTCATCGGAATCTGG CGGGCGTGTCGACGAATCCGAGGGGGAAGGTTCTGGGATTGATTGGACTG GGGAGGATTGGGAGTGAGGTGGTGAGGAAGGTGAGGGGTGGGTTAGGGAT GGAGGTTGTTTATTATGATGCGGTACGGTTGAGTGAGGAGAGGGAGAGGG AGTTGGGGGTGAGATGGGGCGGGGGGATTAGGGGGGTGTTGGAGGGGGCG GATTGTGTGTCGGTGCATTGTCCGTTGACTGAGGGGACCAGGGGGTTGAT CGATAAGGAGAAGATTGGGTGGATGAGGGATGGGGTGAGGGTTGTTAATG TGGCCAGGGGGGGTGTGGTGGTTGAGGAGGATTTGGTGCAGGGGTTGAGG AGTGGGAAGGTGGCTGCTGCGGCGTTGGATGTTCATGAGTTTGAGCCCGT TGTGGATGGTAGACTGAGGGAGATGGAGAATGTTACGCTTACGACGCATG TTGGGGGTGGGGCGGTTGAGACGAGGATTGGGTTTGAGAGGTTGGCGATG GAGAATATTTTGAGGGTAGTCGGGGATGATGGGGAGGTTGTCGGGGAGCC GGTCACGGCTGTTAATGGGAGGGAGGTGAGGGAGGTGTGGGAGAGGATGG GCAAGGGGGAGTGAATGACCAAACCCATAATCCTCCACCTCGGCGACCCC ATCGCCTACAACCACGACCTCTACAACGACCCCCTCTCCACCCGCTTCAC CATCATCCGCGACACCTCCCCAACCCGCGAAGCCTTCATCGAGGCGCTGA AAACCAACAA back to top
Annotated Terms
The following terms have been associated with this mRNA:
Vocabulary: Molecular Function
Term | Definition |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
GO:0051287 | NAD binding |
Vocabulary: Biological Process
Term | Definition |
GO:0055114 | oxidation-reduction process |
Relationships
This mRNA is a part of the following gene feature(s):
The following polypeptide feature(s) derives from this mRNA:
The following CDS feature(s) are a part of this mRNA:
The following exon feature(s) are a part of this mRNA:
Properties
Property Name | Value |
Note | EggNog:ENOG41 |
DBxref | InterPro:IPR036291 |
DBxref | InterPro:IPR029753 |
DBxref | InterPro:IPR006140 |
DBxref | InterPro:IPR006139 |
DBxref | PFAM:PF02826 |
DBxref | PFAM:PF00389 |
Product | hypothetical protein |
Analyses
This mRNA is derived from or has results from the following analyses
Alignments
The following features are aligned
Aligned Feature | Feature Type | Alignment Location |
ch2 | supercontig | ch2:459942..461076 - |
|